Hormonal Contraceptives and Weight Gain
Most hormonal contraceptives do not cause meaningful weight gain; the clear exception is the three-monthly injectable progestogen, which is associated with slow, cumulative gain over years.
Plain English
Patient-Friendly Explanation
A very common worry about hormonal contraception is that it causes weight gain, and for most methods the evidence does not support it. Combined pills, the vaginal ring, the patch, the implant and the hormonal coil have all been studied carefully, and when the trials are pooled, users gain about the same as non-users - often no more than a kilogram either way. The clear exception is the injectable progestogen given every three months, which is linked to a slow, gradual gain: on average a few kilograms in the first year and more with longer use, with the gain tending to be larger in women who are already carrying extra weight. Some women notice bloating or a little fluid retention in the first few months; that usually settles. If weight does rise and stay up, the answer is a review with the prescriber rather than simply stopping, because there are many formulations and routes to choose from, and an unplanned pregnancy has its own risks.
Medical
Clinical Definition
Cochrane systematic reviews and randomised trials show that combined oral contraceptives, the transdermal patch, the vaginal ring, the etonogestrel implant and the levonorgestrel intrauterine system are not associated with clinically significant weight gain: meta-analyses give mean differences of around 0 to 1 kg over 6 to 12 months, and the largest randomised trial (reported in the Cochrane review of combination contraceptives) found no difference from placebo. Depot medroxyprogesterone acetate (DMPA) is the exception. In the Contraceptive CHOICE cohort and other prospective studies, a substantial proportion of DMPA users gained roughly 3 to 6 kg over 12 to 36 months, baseline BMI predicted the magnitude of gain, and return to pre-treatment weight after stopping is variable. Proposed mechanisms include progestogen-mediated effects on appetite and glucocorticoid receptor cross-reactivity; oestrogen-related fluid retention explains early, transient change rather than fat accrual, and the placebo arms of trials show similar initial fluctuations. Practical clinical points: document baseline weight and BMI, review at three months with objective data, and reassure with the trial evidence rather than dismissing the concern. In patients with obesity, contraceptive efficacy must be considered alongside weight: BMI of 30 kg/m2 or above is associated with reduced effectiveness of combined oral contraceptives in some studies, and BMI of 35 kg/m2 or above with reduced patch efficacy and greater DMPA weight gain, so a progestogen implant or an intrauterine device is often preferred. After bariatric surgery, oral absorption is altered and non-oral routes are advised after malabsorptive procedures. Because weight loss itself commonly restores ovulation and fertility, contraception matters more, not less, during and after a weight-management programme.
Key Insight
Why It Matters
The honest answer to whether the pill causes weight gain is almost always no - but the three-monthly injection is a real exception, and knowing that lets a patient choose rather than guess.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
